← Eichor
Condition: Overall Response Rate Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Overall Response Rate

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07448142Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06530576A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizu
Phase 2 · 13 location(s) · Centre Leon Berard · NCT05152472A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of H
NA · 1 location(s) · Fujian Medical University · NCT06277024Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions
Phase 2 · 1 location(s) · Qingdao Central Hospital · NCT07090525Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)
Phase N/A · 1 location(s) · The Second Affiliated Hospital of Hainan Medical University · NCT06531681Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients
Phase 2 · 16 location(s) · Centre Leon Berard · NCT04698785Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors
NA · 1 location(s) · The First Affiliated Hospital of Nanchang University · NCT05749627ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
Phase 1 · 9 location(s) · Adcytherix SAS · NCT07238075The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Phase 3 · 33 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT06520345
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.